AstraZeneca Nolvadex Patent Valid Until 2002, Firm Says After Court Ruling

AstraZeneca expects that generic competition to Nolvadex will be limited to Barr's "authorized" tamoxifen until Aug. 20, 2002, following a Boston federal court ruling against Teva/Pharmachemie.